methyl-3-(benzyloxy)-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-2-carboxylate | 724445-29-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶并嘧啶类
• 英文名称: methyl-3-(benzyloxy)-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-2-carboxylate
• 英文别名: Methyl 3-(benzyloxy)-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-2-carboxylate；methyl 4-oxo-3-phenylmethoxy-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidine-2-carboxylate
• CAS: 724445-29-8
• 化学式: C₁₇H₁₈N₂O₄
• 分子量: 314.341
• InChiKey: IWOUDGARURIUCJ-UHFFFAOYSA-N

物化性质

• 沸点：
  491.2±55.0 °C(Predicted)
• 密度：
  1.29±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  23
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.35
• 拓扑面积：
  68.2
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  methyl-3-(benzyloxy)-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-2-carboxylate 在 palladium on activated charcoal 4-二甲氨基吡啶 、 N-溴代丁二酰亚胺(NBS) 、 氢气 、 三乙胺 、 过氧化苯甲酰 作用下， 以 四氢呋喃 、 甲醇 、 四氯化碳 为溶剂， 反应 6.0h， 生成 methyl 3-(benzoyloxy)-9-bromo-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-2-carboxylate
  参考文献：
  名称：

  The synthesis of tetrahydropyridopyrimidones as a new scaffold for HIV-1 integrase inhibitors

  摘要：

  An efficient synthesis of methyl 9-amino-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-2-carboxylate as a late stage intermediate for a new class of HIV-1 integrase inhibitors is described. After construction of the bicyclic core scaffold, a stereoselective introduction of the chiral amino group in the 9-position is achieved. (C) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2007.07.043
• 作为产物：
  描述：

  2-苯基甲氧基乙酸甲酯 在 1,8-二氮杂双环[5.4.0]十一碳-7-烯 、 lithium diisopropyl amide 作用下， 以 四氢呋喃 、 甲醇 、 正庚烷 、 乙基苯 为溶剂， 生成 methyl-3-(benzyloxy)-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-2-carboxylate
  参考文献：
  名称：

  The synthesis of tetrahydropyridopyrimidones as a new scaffold for HIV-1 integrase inhibitors

  摘要：

  An efficient synthesis of methyl 9-amino-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-2-carboxylate as a late stage intermediate for a new class of HIV-1 integrase inhibitors is described. After construction of the bicyclic core scaffold, a stereoselective introduction of the chiral amino group in the 9-position is achieved. (C) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2007.07.043

文献信息

• [EN] TETRAHYDRO-4H-PYRIDO[1,2-A]PYRIMIDINES AND RELATED COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS<br/>[FR] TETRAHYDRO-4H-PYRIDO[1,2-A]PYRIMIDINES ET COMPOSES CONNEXES CONVENANT COMME INHIBITEURS DE L'INTEGRASE DU VIH
  申请人：ANGELETTI P IST RICHERCHE BIO

  公开号：WO2004058756A1

  公开（公告）日：2004-07-15

  Tetrahydro-4H-pyrido[1,2-a]pyrimidines and related compounds of Formula (A): are described as inhibitors of HIV integrase and inhibitors of HIV replication, wherein n is an integer equal to zero, 1, 2 or 3, and R1, R3, R4, R12, R14, R16, R30, R32, R34 and R36 are defined herein. These compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

  Tetrahydro-4H-pyrido[1,2-a]pyrimidines及其相关化合物的化学式（A）如下：被描述为HIV整合酶的抑制剂和HIV复制的抑制剂，其中n是一个等于零、1、2或3的整数，而R1、R3、R4、R12、R14、R16、R30、R32、R34和R36在此处被定义。这些化合物对预防和治疗HIV感染以及预防、延缓艾滋病发作和治疗艾滋病具有用处。这些化合物可作为化合物本身或作为药学上可接受的盐的形式用于对抗HIV感染和艾滋病。这些化合物及其盐可作为药物组合物的成分，可选择性地与其他抗病毒药物、免疫调节剂、抗生素或疫苗结合使用。
• [EN] TETRAHYDRO-4H-PYRIDO[1,2-A]PYRIMIDINES AND RELATED COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS<br/>[FR] TETRAHYDRO-4H-PYRIDO[1,2-A]PYRIMIDINES ET COMPOSES ASSOCIES UTILISES EN TANT QU'INHIBITEURS DE L'INTEGRASE DU VIH
  申请人：ANGELETTI P IST RICHERCHE BIO

  公开号：WO2004058757A1

  公开（公告）日：2004-07-15

  Tetrahydro-4H-pyrido[1,2-a]pyrimidines and related compounds of Formula (I): are described as inhibitors of HIV integrase and inhibitors of HIV replication, wherein n is an integer equal to zero, 1 or 2, and R1, R3, R4, R12 and R14 are defined herein. These compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

  描述了公式（I）中的四氢-4H-吡啶并[1,2-a]嘧啶及其相关化合物作为HIV整合酶抑制剂和HIV复制抑制剂，其中n是等于零、1或2的整数，R1、R3、R4、R12和R14在此定义。这些化合物对于预防和治疗HIV感染以及预防、延缓发病和治疗艾滋病非常有用。这些化合物可作为化合物本身或药学上可接受的盐的形式用于对抗HIV感染和艾滋病。这些化合物及其盐可作为成分用于制药组合物中，可选择与其他抗病毒药物、免疫调节剂、抗生素或疫苗组合使用。
• Tetrahydro--4h-pyrido[1,2-a}pyrimidines and related compounds useful as hiv integrase inhibitors
  申请人：Crescenzi Benedetta

  公开号：US20060046985A1

  公开（公告）日：2006-03-02

  Tetrahydro-4H-pyrido[1,2-a]pyrimidines and related compounds of Formula (A): are described as inhibitors of HIV integrase and inhibitors of HIV replication, wherein n is an integer equal to zero, 1, 2 or 3, and R 1 , R 3 , R 4 , R 12 , R 14 , R 16 , R 30 , R 32 , R 34 and R 36 are defined herein. These compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

  描述了式（A）的四氢-4H-吡啶并[1,2-a]嘧啶和相关化合物作为HIV整合酶抑制剂和HIV复制抑制剂，其中n是等于零、1、2或3的整数，R1、R3、R4、R12、R14、R16、R30、R32、R34和R36在此定义。这些化合物对预防和治疗HIV感染以及预防、延缓AIDS的发生和治疗都很有用。这些化合物作为化合物本身或以药学上可接受的盐的形式用于对抗HIV感染和AIDS。这些化合物及其盐可以作为药物组成部分使用，可选地与其他抗病毒药物、免疫调节剂、抗生素或疫苗组合使用。
• Tetrahydro-4H-pyrido[1,2-a] pyrimidines useful as HIV integrase inhibitors
  申请人：Crescenzi Benedetta

  公开号：US20080176869A1

  公开（公告）日：2008-07-24

  Tetrahydro-4H-pyrido[1,2-a]pyrimidines and related compounds of Formula A: are described as inhibitors of HIV integrase and inhibitors of HIV replication, wherein n is an integer equal to zero, 1, 2 or 3, and R 1 , R 3 , R 4 , R 12 , R 14 , R 16 , R 30 , R 32 , R 34 and R 36 are defined herein. These compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

  化合物A的四氢-4H-吡啶并[1,2-a]嘧啶和相关化合物被描述为HIV整合酶抑制剂和HIV复制抑制剂，其中n是等于0、1、2或3的整数，R1、R3、R4、R12、R14、R16、R30、R32、R34和R36在此定义。这些化合物对于预防和治疗HIV感染以及预防、延迟发病和治疗艾滋病非常有用。这些化合物可作为化合物本身或作为药物可接受的盐形式用于对抗HIV感染和艾滋病。这些化合物及其盐可作为药物组合中的成分，可选择与其他抗病毒药物、免疫调节剂、抗生素或疫苗组合使用。
• Substituted pyrimido[1,2-a]azepines useful as HIV integrase inhibitors
  申请人：Istituto di Ricerche di Biologia Molecolare P. Angeletti S.p.A.

  公开号：US07414045B2

  公开（公告）日：2008-08-19

  Tetrahydro-4H-pyrido[1,2-a]pyrimidines and related compounds of Formula (A): are described as inhibitors of HIV integrase and inhibitors of HIV replication, wherein n is an integer equal to zero, 1, 2 or 3, and R1, R3, R4, R12, R14, R16, R30, R32, R34 and R36 are defined herein. These compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

  化学式为（A）的四氢-4H-吡啶并[1,2-a]嘧啶及其相关化合物被描述为HIV整合酶抑制剂和HIV复制抑制剂，其中n是等于0、1、2或3的整数，R1、R3、R4、R12、R14、R16、R30、R32、R34和R36在此被定义。这些化合物在预防和治疗HIV感染以及预防、延迟发病和治疗艾滋病方面非常有用。这些化合物可以作为药物本身或以药用盐的形式用于对抗HIV感染和艾滋病。这些化合物及其盐可以作为药物组成部分，可以与其他抗病毒药物、免疫调节剂、抗生素或疫苗组合使用。